Login Start for Free

My Subscriptions My Account My Orders Log Out

Overview
Financial Statements
KPIs & Operating Metrics
Peers
Ownership
- Institutional Ownership
- Insider Ownership
SEC Filings
Charts

KPIs & Operating Metrics(New)

Breakdown Of Assets Collaborations And Licenses Revenue By Category Collaborations And Licenses Revenue By Category Annual Deferred Revenue Employee Statistics Opex As A % Of Total Revenue %OPEX Segregation Profitability Profitability %Profitability Annual Profitability Annual %Property And Equipment Breakdown Revenue By Business Vertical Revenue By Business Vertical %Revenue By Business Vertical Annual Revenue By Business Vertical Annual %Revenue By Segment Revenue By Segment %Revenue By Segment Annual Revenue By Segment Annual %

Balance Sheet

Accounts Payables Accumulated Depreciation Accumulated Expenses Assets Buildings Cash & Equivalents Common Equity Current Assets Current Deferred Revenue Current Deferred Tax Assets Current Leases Finished Goods Goodwill Goodwill & Intangibles Intangibles Liabilities and Shareholders Equity Long-Term Deferred Tax Long-Term Investments Non-Current Assets Non-Current Debt Non-Current Deferred Tax Liability Non-Current Deffered Revenue Operating Leases Other Accumulated Expenses Other Non-Current Assets Other Non-Current Liabilities Payables Preferred Shares Prepaid Assets Property, Plant & Equipment (Net)Receivables Receivables - Accured Receivables - Net Receivables - Other Retained Earnings Shareholder's Equity Shares Outstanding Short term Debt Total Current Liabilities Total Debt Total Liabilities Total Non-Current Liabilities Treasury Shares

Cash Flow Statement

Acquisitions Amortization of Goodwill Amortizatization of Intangibles Asset Writedowns and Impairment Capital Expenditures Cash from Financing Activities Cash from Investing Activities Cash from Operations Cash from Restructuring Change in Accured Expenses Change in Acquisitions & Divestments Change in Cash Change in Inventory Change in Receivables Change in Taxes Deferred Taxes Depreciation & Amortization (CF)Depreciation and Depletion Dividends Paid - Preferred Exchange Rate Effect Free Cash Flow Gains from Investment Securities Long-Term Debt Repayments Net Cash Flow Net Income Non-cash Items Other financing activities Preferred Shares Issued Sales of Property, Plant and Equipment Share-based Compensation Shares Issued

Daily Values

DMA 100 DMA 200 DMA 50 Dividend Yield EV to CFO EV to EBIT EV to EBITDA EV to FCF EV to Revenue Market Cap to FCF Price Price to Book Price to Earnings Price to Sales

Growth Metrics

EBIT Margin (QoQ)EBIT Margin Growth (1y)EBIT Margin Growth (3y)EBIT Margin Growth (5y)EBITDA Margin (QoQ)EBITDA Margin Growth (1y)EBITDA Margin Growth (3y)EBITDA Margin Growth (5y)EBT Margin (QoQ)EBT Margin Growth (1y)EBT Margin Growth (3y)EBT Margin Growth (5y)Enterprise Value (QoQ)Enterprise Value Growth (1y)Enterprise Value Growth (3y)Enterprise Value Growth (5y)FCF Margin (QoQ)FCF Margin Growth (1y)FCF Margin Growth (3y)FCF Margin Growth (5y)Gross Margin (QoQ)Gross Margin Growth (1y)Gross Margin Growth (3y)Gross Margin Growth (5y)Net Margin (QoQ)Net Margin Growth (1y)Net Margin Growth (3y)Net Margin Growth (5y)Operating Margin (QoQ)Operating Margin Growth (1y)Operating Margin Growth (3y)Operating Margin Growth (5y)Return on Assets (QoQ)Return on Assets Growth (1y)Return on Assets Growth (3y)Return on Assets Growth (5y)Return on Capital Employed (QoQ)Return on Capital Employed Growth (1y)Return on Capital Employed Growth (3y)Return on Capital Employed Growth (5y)Return on Equity (QoQ)Return on Equity Growth (1y)Return on Equity Growth (3y)Return on Equity Growth (5y)Return on Invested Capital Growth (1y)Return on Sales (QoQ)Return on Sales Growth (1y)Return on Sales Growth (3y)Return on Sales Growth (5y)

Income Statement

Amortization - Intangibles Consolidated Net Income Depreciation & Amortization - Total EBIT EBITDA EBT EPS (Basic)EPS (Weighted Average and Diluted)Equity Income Gross Profit Income from Continuing Operations Income towards Parent Company Interest & Investment Income Net Income towards Common Stockholders Non Operating Income Operating Expenses Operating Income Other Non Operating Income Other Operating Expenses Preferred Dividend Payments Profit After Tax Research & Development Restructuring Costs Revenue Selling, General & Administrative Shares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions Tax Rate

Others

Accumulated Depreciation & Amortization Amortization - Goodwill Depreciation Expense Leases Machine, Furnitures, Fixtures & Other Other Gross PP&E Adjustments Property, Plant & Equipment (Gross)R&D In Process Revenue - Other

Ratios

Asset Utilization Ratio Assets Average Debt Ratio Debt to Equity EBIT Margin EBITDA Margin EBT Margin Enterprise Value Equity Average Equity Ratio FCF Margin Gross Margin Interest Coverage Ratio Invested Capital Market Capitalization Net Margin Operating Margin Return on Assets Return on Capital Employed Return on Equity Return on Invested Capital Return on Sales Times Interest Earned

Arbutus Biopharma (ABUS) Deferred Revenue: 2021-2024

Generated on {Timestamp} © BusinessQuant.com

Generated on {Timestamp} Powered by

Peer Comparison

Historic Data

Download Data 🔒

Date	Value

×

Your powerful stock research platform

Resources

About Us
Sitemap
Contact Us

Company

Terms of Use
Privacy Policy
Plans & Pricing
Schedule a Demo

Create an account

Start your journey with us today. It's free!

I agree to the privacy policy.

Have an account already? Sign In

Sign In

Welcome back! Please enter your details.

Remember Me

Forgot Password?

Don't have an account? Create one now

Reset Password

Enter your email to receive a reset link.

Back to Sign In

Get Pro for 60% off

Access all features immediately
Segment financials and operating data
Export data in CSV and XLSX formats

Offer Ends In

00Days

00Hours

00Minutes

00Seconds

Starting from ~~$49~~ $19 / month

Claim Discount